Both BNP and NT-proBNP are independent prognostic factors in cardiac amyloidosis patients, but BNP showed superior prognostic value in patients that were also associated with end stage kidney disease, as the impact of reduced eGFR was greater on NT-proBNP than on BNP [6]. This evidence concerns the gene NPPB and cardiac amyloidosis.